ESR1 and thyroid cancer: The ability of an anti-estrogen to inhibit any direct effect of estrogen on thyroid cancer cells suggests that the estrogen receptor is a viable target for treatment of thyroid cancer by way of using anti-estrogens in therapeutic and preventive settings.